Table 3.
GLP-1R activation and nLuc-GLP-1R affinity for GLE and analogues.
| GLP-1R cAMP Production | nLuc-GLP-1R Affinity | ||||
|---|---|---|---|---|---|
| Peptide | EC50 (nM) | EC50 relative | % Max | IC50 (nM) | IC50 relative |
| GLE | 5.1 | 1 | 95 ± 2 | 290 | 1 |
| GLE L-Ala | >1000 | >200 | NR | 390 | 1 |
| GLE D-Ala | 21 | 4 | 21 ± 2 | 250 | 0.9 |
| GLE (S,S)-ACPC | >1000 | >200 | NR | 15 | 0.05 |
| GLE (R,R)-ACPC | >1000 | >200 | NR | 160 | 0.6 |
| GLE β-hGly | >1000 | >200 | NR | 120 | 0.4 |
EC50 and maximal response (% Max) values were derived from ≥4 independent experiments. EC50 relative indicates potency normalized to GLE (GLE analogue/GLE). For nLuc-GLP-1R competition binding experiments, IC50 values represent the average of 4 independent experiments. IC50 relative indicates affinity normalized to GLE (GLE analogue/GLE). NR = No Response.